Search results for "Glucose transporter"

showing 10 items of 60 documents

RS1 (Rsc1A1) deficiency limits cerebral SGLT1 expression and delays brain damage after experimental traumatic brain injury

2018

Acute cerebral lesions are associated with dysregulation of brain glucose homeostasis. Previous studies showed that knockdown of Na+ -D-glucose cotransporter SGLT1 impaired outcome after middle cerebral artery occlusion and that widely expressed intracellular RS1 (RSC1A1) is involved in transcriptional and post-translational down-regulation of SGLT1. In the present study, we investigated whether SGLT1 is up-regulated during traumatic brain injury (TBI) and whether removal of RS1 in mice (RS1-KO) influences SGLT1 expression and outcome. Unexpectedly, brain SGLT1 mRNA in RS1-KO was similar to wild-type whereas it was increased in small intestine and decreased in kidney. One day after TBI, SGL…

Male0301 basic medicinemedicine.medical_specialtyTraumatic brain injuryGene ExpressionBrain EdemaBrain damageBiochemistryProinflammatory cytokineMice03 medical and health sciencesCellular and Molecular NeuroscienceSodium-Glucose Transporter 10302 clinical medicineInternal medicineCortex (anatomy)Brain Injuries TraumaticmedicineAnimalsGlucose homeostasisEye ProteinsBrain ChemistryCerebral CortexMice KnockoutGene knockdownKidneyMovement DisordersMicrogliabusiness.industrydigestive oral and skin physiologyBrainmedicine.diseaseUp-RegulationMice Inbred C57BL030104 developmental biologymedicine.anatomical_structureEndocrinologyCytokinesMicrogliamedicine.symptombusinessCell Adhesion Molecules030217 neurology & neurosurgeryJournal of Neurochemistry
researchProduct

The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics

2020

Abstract Background The Dapagliflozin and Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD; NCT03036150) trial was designed to assess the effect of the sodium–glucose co-transporter 2 (SGLT2) inhibitor dapagliflozin on kidney and cardiovascular events in participants with CKD with and without type 2 diabetes (T2D). This analysis reports the baseline characteristics of those recruited, comparing them with those enrolled in other trials. Methods In DAPA-CKD, 4304 participants with a urinary albumin:creatinine ratio (UACR) ≥200 mg/g and estimated glomerular filtration rate (eGFR) between 25 and 75 mL/min/1.73 m2 were randomized to dapagliflozin 10 mg once daily or placebo. Me…

MaleIGA NEPHROPATHYRATIONALEPROGRESSIONType 2 diabetesurologic and male genital diseasesDiabetic nephropathychemistry.chemical_compoundGlucosidesDESIGNMedicineFAILUREDiabetic NephropathiesDapagliflozinrandomized controlled clinical trialPrognosisfemale genital diseases and pregnancy complications//purl.org/pe-repo/ocde/ford#3.02.13 [https]Cardiovascular DiseasesNephrologyFemalesodium–glucose co-transporter-2 inhibitormedicine.symptomBENAZEPRILGlomerular Filtration Ratemedicine.medical_specialtyFinerenoneINHIBITIONNephropathy//purl.org/pe-repo/ocde/ford#3.02.20 [https]Double-Blind MethodClinical ResearchInternal medicineDiabetes mellitusEND-POINTSHumansBenzhydryl CompoundsRenal Insufficiency ChronicAcademicSubjects/MED00340Sodium-Glucose Transporter 2 InhibitorsAgedTransplantationDECLINEbusiness.industrysodium-glucose co-transporter-2 inhibitordapagliflozinmedicine.diseaseEFFICACYEditor's ChoiceDiabetes Mellitus Type 2chemistryAlbuminuriaORIGINAL ARTICLESbusinesschronic kidney diseaseKidney disease
researchProduct

Glucose/galactose malabsorption caused by a defect in the Na+/glucose cotransporter.

1991

Glucose/galactose malabsorption (GGM) is an autosomal recessive disease manifesting within the first weeks of life and characterized by a selective failure to absorb dietary glucose and galactose from the intestine. The consequent severe diarrhoea and dehydration are usually fatal unless these sugars are eliminated from the diet. Intestinal biopsies of GGM patients have revealed a specific defect in Na(+)-dependent absorption of glucose in the brush border. Normal glucose absorption is mediated by the Na+/glucose cotransporter in the brush border membrane of the intestinal epithelium. Cellular influx is driven by the transmembrane Na+ electrochemical potential gradient; thereafter the sugar…

MaleModels MolecularBrush borderMonosaccharide Transport ProteinsProtein ConformationMolecular Sequence DataCarbohydrate metabolismPolymerase Chain Reactionchemistry.chemical_compoundMalabsorption SyndromesReference ValuesmedicineHumansMultidisciplinarySLC5A1biologyBase SequenceGlucose transporterGalactoseDNACarbohydratemedicine.diseaseMolecular biologyAntisense Elements (Genetics)GlucosechemistryBiochemistryGlucose-galactose malabsorptionGalactoseChild PreschoolMutationbiology.proteinFemaleCotransporterOligonucleotide ProbesNature
researchProduct

Ketogenic diet for infants with epilepsy: A literature review.

2020

Abstract The ketogenic diet (KD) is an established, nonpharmacological treatment for drug-resistant epilepsy (DRE). Actually, KD and its variants have been shown to be elective and resolute for patients with glucose transporter type 1 (GLUT1) deficiency. The aim of this review was to study the use of KD and its variants in infancy, including the neonatal age, and demonstrate the safety and efficacy of this treatment in patients with the age of 0–23 months affected by DRE already subjected to pharmacological approach attempts. A literature search was conducted using PubMed as the medical database source. We used the age limit of 0–23 months, and we considered only articles published between …

MalePediatricsmedicine.medical_specialtyDrug Resistant EpilepsyKetogenicmedicine.medical_treatmentDrug-resistant epilepsyDrug-resistant epilepsy Epilepsy Glucose transporter type 1 deficiency Infant Ketogenic diet Diet Ketogenic Disease Management Drug Resistant Epilepsy Epilepsy Female Glucose Transporter Type 1 Humans Infant. Infant Newborn. Male Seizures Treatment OutcomeNeonatal ageNewborn. MaleAge limitlaw.invention03 medical and health sciencesBehavioral NeuroscienceEpilepsy0302 clinical medicineRandomized controlled triallawSeizuresmedicineGlucose transporter type 1 deficiencyHumans030212 general & internal medicineProspective cohort studyGlucose Transporter Type 1Epilepsybusiness.industryInfant NewbornDisease ManagementInfantRetrospective cohort studyKetogenic dietInfant. InfantDrug Resistant Epilepsymedicine.diseaseDietTreatment OutcomeNeurologyFemaleNeurology (clinical)businessDiet Ketogenic030217 neurology & neurosurgeryKetogenic dietEpilepsybehavior : EB
researchProduct

Olfactory discrimination ability and brain expression of c-fos, Gir and Glut1 mRNA are altered in n-3 fatty acid-depleted rats

2007

Abstract The long-chain polyunsaturated n  − 3 fatty acids ( n  − 3 PUFA), particularly docosahexaenoic acid (DHA), are abundantly present in the central nervous system and play an important role in cognitive functions such as learning and memory. We, therefore, investigated the effects of n  − 3 PUFA-depletion in rats (F2 generation) on the learning of an olfactory discrimination task, progressively acquired within a four-arm maze, and on the mRNA expression of some candidate genes, i.e., c-fos, Gir and glucose transporter (Glut1), which could reflect the level of cerebral activity. We observed that DHA contents were dramatically decreased in the olfactory bulb, the piriform cortex and the…

MaleTime Factors[SDV]Life Sciences [q-bio]OLFACTORY LEARNINGReceptors G-Protein-CoupledDiscrimination LearningBehavioral Neuroscience0302 clinical medicineDiscrimination PsychologicalPiriform cortexBRAINDiet Fat-Restricted0303 health sciencesGlucose Transporter Type 1NeocortexBehavior AnimalGIRReverse Transcriptase Polymerase Chain ReactionSmellmedicine.anatomical_structureBiochemistryDocosahexaenoic acidN−3 DEFICIENCYOlfactory LearningProto-Oncogene Proteins c-fosmedicine.medical_specialtyN-3 PUFAC-FOSCentral nervous systemOlfactionBiologyAPPRENTISSAGE03 medical and health sciencesInternal medicineFatty Acids Omega-3medicineAnimalsRNA MessengerRats WistarUnsaturated fatty acid030304 developmental biologyAnalysis of VarianceBody WeightDOCOSAHEXAENOIC ACIDOlfactory bulbRatsEndocrinologyGene Expression RegulationRAT030217 neurology & neurosurgeryGLUT1
researchProduct

Influence of metformin on GLUT1 gene and protein expression in rat streptozotocindiabetes mellitusmodel

2010

Metformin improves hyperglycaemia via mechanisms which include activation of AMP-activated protein kinase (AMPK). Recent findings indicate that some metabolic actions of metformin occur also by AMPK-independent mechanisms.To study the action of metformin on expression of GLUT1 glucose transporter in rat streptozotocin model of diabetes mellitus.Streptozotocin-induced rats were treated with metformin while monitoring parameters of carbohydrate and lipid metabolism. GLUT1 mRNA and protein expression in kidneys, heart, liver and muscles were studied by means of real time quantitative RT-PCR and immunohistochemistry correspondingly.Metformin treatment decreased glucose concentration, glycated h…

Maleendocrine systemmedicine.medical_specialtyendocrine system diseasesPhysiologyCarbohydrate metabolismDiabetes Mellitus ExperimentalPhysiology (medical)Internal medicineDiabetes mellitusmedicineAnimalsHypoglycemic AgentsRats WistarGlycated HemoglobinGlucose Transporter Type 1Glucose tolerance testmedicine.diagnostic_testbiologybusiness.industrydigestive oral and skin physiologyGlucose transporternutritional and metabolic diseasesAMPKGeneral MedicineGlucose Tolerance TestStreptozotocinmedicine.diseaseMetforminRatsMetforminDisease Models AnimalGlucoseEndocrinologyGene Expression Regulationbiology.proteinGLUT1businessmedicine.drugArchives of Physiology and Biochemistry
researchProduct

Effects of insulin-like growth factor I on the rates of glucose transport and utilization in rat skeletal muscle in vitro.

1992

1. The effects of insulin-like growth factor I (IGF-I) on the rates of glucose transport and utilization and its interaction with insulin were investigated in rat soleus muscle in vitro. IGF-I increased the rates of glucose transport, lactate formation, glycogen synthesis and the flux of glucose to hexose monophosphate, but it had no effect on the rate of glucose oxidation or glycogenolysis. 2. In the absence of insulin, low levels of IGF-I (0-30 ng/ml) increased the rate of glycolysis and the content of fructose 2,6-bisphosphate, but the content of glucose 6-phosphate remained unaltered; at higher levels of IGF-I (300-3000 ng/ml) the rate of glycolysis and the content of fructose 2,6-bisph…

Malemedicine.medical_specialtyGlycogenolysismedicine.medical_treatmentGlucose-6-PhosphateBiologyIn Vitro TechniquesBiochemistrychemistry.chemical_compoundInternal medicinemedicineFructosediphosphatesAnimalsInsulinGlycolysisInsulin-Like Growth Factor IPhosphorylationGlycogen synthaseMolecular BiologyGlycogenInsulinMusclesGlucose transporterGlucosephosphatesFructoseBiological TransportRats Inbred StrainsCell BiologyRatsKineticsEndocrinologyGlucosechemistryFructolysisbiology.proteinGlycolysisOxidation-ReductionGlycogenResearch Article
researchProduct

Effects of glucocorticoid excess on the sensitivity of glucose transport and metabolism to insulin in rat skeletal muscle.

1997

This study examines the mechanisms of glucocorticoid-induced insulin resistance in rat soleus muscle. Glucocorticoid excess was induced by administration of dexamethasone to rats for 5 days. Dexamethasone decreased the sensitivity of 3-O-methylglucose transport, 2-deoxyglucose phosphorylation, glycogen synthesis and glucose oxidation to insulin. The total content of GLUT4 glucose transporters was not decreased by dexamethasone; however, the increase in these transporters in the plasma membrane in response to insulin (100 m-units/litre) was lessened. In contrast, the sensitivity of lactate formation to insulin was normal. The content of 2-deoxyglucose in the dexamethasone-treated muscle was …

Malemedicine.medical_specialtyMonosaccharide Transport Proteinsmedicine.medical_treatmentBlotting WesternGlucose-6-PhosphateMuscle ProteinsDeoxyglucoseBiochemistryDexamethasonechemistry.chemical_compoundInsulin resistanceInternal medicineHexokinasemedicineFructosediphosphatesAnimalsInsulinGlycolysisLactic AcidPhosphorylationRats WistarGlycogen synthaseMuscle SkeletalMolecular BiologyGlucocorticoidsHexokinaseGlucose Transporter Type 4biologyInsulinGlucose transporterCell BiologyMetabolismmedicine.diseaseRatsEndocrinologyGlucosechemistrybiology.protein3-O-MethylglucoseGLUT4GlycogenResearch Article
researchProduct

Expression of Na+-d-glucose cotransporter SGLT2 in rodents is kidney-specific and exhibits sex and species differences

2012

With a novel antibody against the rat Na+-d-glucose cotransporter SGLT2 (rSGLT2-Ab), which does not cross-react with rSGLT1 or rSGLT3, the ∼75-kDa rSGLT2 protein was localized to the brush-border membrane (BBM) of the renal proximal tubule S1 and S2 segments (S1 > S2) with female-dominant expression in adult rats, whereas rSglt2 mRNA expression was similar in both sexes. Castration of adult males increased the abundance of rSGLT2 protein; this increase was further enhanced by estradiol and prevented by testosterone treatment. In the renal BBM vesicles, the rSGLT1-independent uptake of [14C]-α-methyl-d-glucopyranoside was similar in females and males, suggesting functional contribution of…

Malemedicine.medical_specialtyPhysiologyImmunocytochemistryCarbohydrate metabolismBiologyKidneyMicechemistry.chemical_compoundimmunocytochemistry; mRNA expression; Na+-D-glucose cotransport;Sex FactorsSodium-Glucose Transporter 2D-GlucoseInternal medicinemedicineAnimalsTestosteroneCastrationRNA MessengerRats WistarKidneyMembrane Transporters Ion Channels and PumpsEstradiolMicrovilliSymportersGalactoseKidney metabolismCell BiologyRatsMice Inbred C57BLGlucosemedicine.anatomical_structureEndocrinologychemistryGalactoseSymporterFemaleCotransporterAmerican Journal of Physiology-Cell Physiology
researchProduct

The effects of insulin on transport and metabolism of glucose in skeletal muscle from hyperthyroid and hypothyroid rats.

1997

The effects of insulin on the rates of glucose disposal were studied in soleus muscles isolated from hyper- or hypothyroid rats. Treatment with triiodothyronine for 5 or 10 days decreased the sensitivity of glycogen synthesis but increased the sensitivity of lactate formation to insulin. The sensitivity of 3-O methylglucose to insulin was increased only after 10 days of treatment and was accompanied by an increase in the sensitivity of 2-deoxyglucose phosphorylation; however, 2-deoxyglucose and glucose 6-phosphate in response to insulin remained unaltered. In hypothyroidism, insulin-stimulated rates of 3-O-methylglucose transport and 2-deoxyglucose phosphorylation were decreased; however, a…

Malemedicine.medical_specialtymedicine.medical_treatmentClinical BiochemistryBiological Transport ActiveBiologyCarbohydrate metabolismIn Vitro TechniquesBiochemistryHyperthyroidismDinoprostonechemistry.chemical_compoundHypothyroidismInternal medicinemedicineAnimalsInsulinGlycolysisDrug InteractionsLactic AcidPhosphorylationRats WistarGlycogen synthaseMuscle SkeletalHexokinaseInsulinGlucose transporterGeneral MedicineMetabolismRatsCortisoneEndocrinologyGlucosechemistryBasal (medicine)Growth Hormonebiology.proteinTriiodothyronineGlycolysisGlycogenEuropean journal of clinical investigation
researchProduct